Antimicrobial Resistance (AMR) and the Launch of Indigenous Antibiotic Nafithromycin

The Ministry of Science & Technology has launched Nafithromycin, India’s first indigenous antibiotic to combat drug-resistant infections.

1. Context and Background

• What is AMR?
• Antimicrobial Resistance (AMR) occurs when microorganisms like bacteria, viruses, and fungi develop resistance to antimicrobial drugs, rendering them ineffective.
• AMR is a global health threat, often leading to superbugs that are difficult to treat.
• Global Recognition by WHO:
• The World Health Organization (WHO) identifies AMR as one of the top 10 threats to global health.
• Launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to monitor resistance patterns globally.
• India’s Challenge with AMR:
• India is among the world's largest antibiotic consumers, leading to significant risks of resistance.
• The healthcare, agricultural, and environmental sectors are heavily impacted by rising AMR cases.

2. Causes of Rising AMR

1.     Overuse of Antibiotics:

o    Widespread and inappropriate use of antibiotics in humans, livestock, and agriculture increases resistance.

2.     Inadequate Infection Control:

o    Poor sanitation and hygiene promote the spread of resistant microorganisms.

3.     Genetic Mutations:

o    Microbes naturally evolve or develop mutations that enable them to resist drugs.

4.     Lack of R&D:

o    There is insufficient investment in the development of new antimicrobial drugs.

3. Impacts of AMR

1.     Prolonged Illnesses:

o    Resistant infections take longer to treat, increasing morbidity and mortality.

2.     Increased Healthcare Costs:

o    Treatment becomes expensive due to the need for advanced or combination therapies.

3.     Widespread Infections:

o    Resistant infections can spread rapidly across communities and healthcare settings.

4.     Specific Examples:

o    Klebsiella pneumoniae: Resistance to carbapenem antibiotics.

o    Mycobacterium tuberculosis: Resistant to Rifampicin (RR-TB).

o    HIV: Drug-resistant strains reduce the efficacy of antiretroviral drugs.

4. India’s Initiatives Against AMR

1.     National Action Plan on AMR (2017):

o    Adopts a One Health approach, integrating human, animal, and environmental health.

2.     Antibiotic Stewardship Program:

o    Launched by the Indian Council of Medical Research (ICMR) to regulate antibiotic use.

3.     Surveillance Programs:

o    Focused on AMR in microbes causing diseases like tuberculosis, AIDS, and vector-borne infections.

5. Launch of Indigenous Antibiotic Nafithromycin

• Significance:
• Launched as India’s first indigenous antibiotic aimed at combating AMR.
• Developed with the support of the Biotechnology Industry Research Assistance Council (BIRAC).
• Key Features:
• First antibiotic in its class in over 30 years.
• Designed to treat Community-Acquired Bacterial Pneumonia (CABP) caused by drug-resistant bacteria like Streptococcus pneumoniae.
• Market Launch:
• Marketed under the brand name Miqnaf by Wockhardt.
• Global Context:
• Coincides with World AMR Awareness Week (18-24 November 2024).
• Theme: "Preventing Antimicrobial Resistance Together."

6. Relevance of Nafithromycin for India

1.     Addressing Critical Gaps:

o    Targets drug-resistant bacteria, especially in community-acquired infections.

2.     Promoting Indigenous R&D:

o    Demonstrates India's capability to develop new antibiotics for global challenges.

3.     Supporting Global AMR Goals:

o    Aligns with WHO’s call for new antimicrobial solutions to counter resistance.

7. Way Forward

1.     Strengthen Research and Development:

o    Increase funding and incentives for developing new antibiotics and alternative treatments.

2.     Public Awareness:

o    Educate communities on the proper use of antibiotics to reduce misuse.

3.     Policy and Global Collaboration:

o    Collaborate internationally for surveillance, regulation, and sharing best practices.

4.     Integration of One Health Approach:

o    Holistic AMR management, addressing human, animal, and environmental health together.

Conclusion

The launch of Nafithromycin marks a significant milestone in India’s fight against AMR, highlighting the importance of indigenous innovation. However, combating AMR requires a multi-sectoral, sustained approach integrating research, public awareness, and global partnerships to mitigate its devastating impacts on health and development.

MCQs for Practice

1. With reference to Antimicrobial Resistance (AMR), consider the following statements:

1.     AMR occurs when microorganisms become resistant to antimicrobial drugs such as antibiotics.

2.     The World Health Organization (WHO) has identified AMR as one of the top 10 threats to global health.

3.     The misuse of antibiotics in humans, livestock, and agriculture is a major contributor to AMR.

Which of the statements given above are correct?

(a) 1 and 2 only
(b) 2 and 3 only
(c) 1 and 3 only
(d) 1, 2, and 3

Answer: (d)

2. What is the significance of Nafithromycin, recently launched in India?

1.     It is India’s first indigenous antibiotic to combat AMR.

2.     It is designed to treat Community-Acquired Bacterial Pneumonia (CABP).

3.     It is the first antibiotic in its class developed globally in over 30 years.

Select the correct answer using the code given below:

(a) 1 and 2 only
(b) 2 and 3 only
(c) 1 and 3 only
(d) 1, 2, and 3

Answer: (d)

3. With reference to India’s initiatives against AMR, consider the following statements:

1.     The National Action Plan on AMR adopts a One Health approach, integrating human, animal, and environmental health.

2.     The Antibiotic Stewardship Program is led by the Biotechnology Industry Research Assistance Council (BIRAC).

3.     India monitors AMR in diseases like tuberculosis, AIDS, and vector-borne infections.

Which of the statements given above is/are correct?

(a) 1 and 2 only
(b) 2 and 3 only
(c) 1 and 3 only
(d) 1, 2, and 3

Answer: (c)

4. Consider the following statements regarding the causes of AMR:

1.     Poor sanitation and infection control practices.

2.     Overuse and misuse of antibiotics.

3.     Increased genetic mutations in microorganisms.

4.     Over-reliance on vaccines for bacterial infections.

Which of the statements given above contribute to AMR?

(a) 1, 2, and 3 only
(b) 2 and 4 only
(c) 1 and 4 only
(d) 1, 2, 3, and 4

Answer: (a)

5. Which of the following is the theme of World Antimicrobial Resistance Awareness Week (18-24 November 2024)?

(a) Combating Drug-Resistant Infections Together
(b) Preventing Antimicrobial Resistance Together
(c) Building a Global Response to AMR
(d) Mitigating Antimicrobial Resistance Worldwide

Answer: (b)